Hints and tips:
Related Special Reports
...The UK regulator, the Medicines and Healthcare products Regulatory Agency, has approved the drug in limited settings....
...The recovery in global corporate bond and loan markets began after the Federal Reserve signalled it sees a path to cutting interest rates later this year....
...A version of this article was first published by Nikkei Asia on September 28. ©2023 Nikkei Inc. All rights reserved....
...Just this year, a change to medical billing laws wiped out KKR’s $3.5bn equity investment in bankrupt Envision Healthcare. Senior creditors will probably take losses....
...From carworkers to actors, baristas to healthcare workers, the number of people protesting tripled from the preceding year, the FT writes....
...Healthcare is struggling with high input costs (it’s the pickleball plague!)....
...They included Vice Media and Envision Healthcare, whose backers included some of the world’s best-known investors. The court filings are instructive....
...But the National Healthcare Security Administration, which negotiates drug prices for China’s national health insurance reimbursement scheme, balked at the “high price” quoted by Pfizer....
...In trials, an oral antiviral made by Chinese company Shanghai Junshi Biosciences outperformed Paxlovid, cutting the median time to recovery....
...caused hearing loss, is following a recent trend whereby US corporations make use of the bankruptcy court not because they are insolvent but to manage tort claims. 3M is following in the footsteps of healthcare...
...For his patients, he says robot-assisted surgery has shortened their wait to be discharged, reduced complications after surgery, and sped up recovery times....
...The disclosure came as J&J increased its 2021 profit forecast following strong third-quarter earnings growth driven by a broad recovery across its main healthcare divisions, as Covid-19 restrictions ease...
...Investors also hope the antiviral could speed the recovery of the whole economy....
...On the other hand, signs of a Covid recovery left some companies facing reduced demand, particularly makers of healthcare products....
...It ran into trouble after expanding aggressively into technology, finance, commodities, healthcare and property....
...A risk of overwhelming the healthcare system remains, even where high vaccination rates have weakened the link between cases and hospitalisations....
...The same groups are experiencing slower economic recoveries from the pandemic....
...This is part of a series, ‘Economists Exchange’, featuring conversations between top FT commentators and leading economists about the coronavirus economic recovery It is almost two years since the first...
...If the US continues with its K-shaped recovery, the IMF’s prediction of post-pandemic upheaval may prove prescient. Edward Luce is on book leave and will return in mid-March....
...Additional reporting by Ella Hermonio in Manila A version of this article was first published by Nikkei Asia on April 27 2022. ©2022 Nikkei Inc. All rights reserved....
...South Korean retail investors have piled into popular short targets in recent days including Celltrion, the healthcare company....
...Andrew Dickinson, chief financial officer, said the forecasts assumed a recovery in the market starting in the second quarter, as vaccination programmes speed up....
...The NIH study initially said remdesivir speeded up recovery but did not improve survival rates....
...Trials have shown that remdesivir can speed up recovery but it has shown little effect on how likely patients are to survive....
...Coronavirus has also helped boost the profits of healthcare and technology groups....
International Edition